References
- ADAM Medical Encyclopedia. Coronary Heart Disease. Atlanta, GA: ADAM Inc., 2014. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/007115.htm [Last accessed 17 September 2014]
- Go A, Mozzafarian D, Roger V, et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation 2013;127:e6-245
- Lloyd-Jones D, Adams R, Brown T, et al. Executive summary: heart disease and stroke statistics – 2010 update. A report from the American Heart Association. Circulation 2010;121:948-54
- Heidenreich P, Trogdon J, Khavjou O, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011;123:933-44
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421
- Kuklina E, Carroll M, Shaw K, Hirsch R. Trends in High LDL Cholesterol, Cholesterol-lowering Medication Use, and Dietary Saturated-fat Intake: United States, 1976–2010. NCHS Data Brief 2013, Centers for Disease Control and Prevention (CDC) 2013;117:1-8
- Grundy S, Cleeman J, Merz C, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39
- Gibbons G, Shurin S, Mensah G, Lauer M. Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute. Circulation 2013;128:1713-15
- Bertoni A, Bonds D, Steffes S, et al. Quality of cholesterol screening and management with respect to the National Cholesterol Education’s Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina. Am Heart J 2006;152:785-92
- Parker D, Gramling R, Goldman R, et al. Physicians’ perceptions of barriers and facilitators regarding adoption of the National Cholesterol Education Program guidelines. Prev Cardiol 2008;11:29-35
- Deyo R, Cherkin D, Ciol M. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
- Wong N, Chuang J, Wong K, et al. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009–2010). Am J Cardiol 2013;112:373-9
- Nau D. Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence. Pharmacy Quality Alliance, 2012. Available at: http://pqaalliance.org/resources/adherence.asp [Last accessed 17 September 2014]
- GRACE Principles: Good ReseArch for Comparative Effectiveness. The GRACE Initiative, 2010. Available at: http://www.graceprinciples.org/ [Last accessed 17 September 2014]
- Motheral B, Brooks J, Clark MA, et al. A checklist for retrospective database studies – report of the ISPOR Task Force on Retrospective Databases. Value Health 2003;6:90-7
- Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA 1998;279:1458-62
- Cheetham T, Niu F, Green K, et al. Primary nonadherence to statin medications in a managed care organization. J Manag Care Pharm 2013;19:367-73
- Eaton C, Parker D, Borkan J, et al. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Ann Fam Med 2011;9:528-37